A 32-year-old man presented to the emergency department complaining of pleuritic chest pain, productive cough, shortness of breath, and facial swelling. Contrastenhanced chest CT demonstrated a large anterior mediastinal mass and lymphadenopathy with resultant severe narrowing of the superior vena cava (Fig. 1 ). There was a geographic region of poorly defined hypoattenuation involving segment IV of the left lobe of the liver, without evidence of architectural distortion or mass effect, on pulmonary arterial phase postcontrast images (Fig. 2) . The differential diagnosis for this lesion included focal fatty infiltration versus metastatic disease; however, malignancy was considered less likely given the shape, location, and lack of mass effect related to the lesion.
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We present a case of focal increased intrahepatic radiotracer activity on 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) in a patient with lymphoma and superior vena cava (SVC) obstruction, a false positive for malignancy. Contrast-enhanced computed tomography (CT) demonstrated an enhancing region of geographic focal hypoattenuation in the liver along the falciform, corresponding to the region of increased radiotracer activity on FDG-PET, with marked narrowing of the superior vena cava and resultant collateral venous pathways to the portal vein via paraumbilical veins. CT followup demonstrated stability of the hepatic abnormality, and no lesion was evident on ultrasound, suggesting that the finding on PET-CT represented a false positive for malignancy in this patient with known SVC obstruction. In patients with SVC obstruction, radiologists should consider this phenomenon of anomalous hepatic uptake along the falciform as a source of possible false positives for malignancy on PET. with the patient's known lymphoma (maximum standardized uptake value, SUVmax, 9.4) (Fig. 6b) . Besides the known mediastinal lymphoma, the only other concerning PET finding was focally increased FDG accumulation of moderate intensity corresponding to a poorly defined 2.5-x-3.0cm hypoattenuating region toward the inferior aspect of segment IV of the left lobe of the liver adjacent to the falciform ligament, with SUVmax of 5.0 (Fig. 6 ). The differential for focally increased hepatic activity generally includes misregistration artifact from diaphragmatic motion and metabolic activity within the adjacent bowel (which had been confidently excluded in this case, as there was no evidence of misregistration, no nearby bowel activity of sufficient intensity to account for the hepatic finding, and the focal increased hepatic activity conformed to the shape of the liver in three planes and on the MIP, corresponding to the finding on CT) versus primary or secondary hepatic neoplasm, most likely metastatic lymphoma in this case. When interventional radiology (IR) was consulted for liver biopsy and reviewed the CT findings, IR strongly concurred with the CT interpretation favoring a benign etiology for the CT finding, which had been stable in size for three months, likely related to collateral blood flow, prompting the question, "Could the focal abnormal increased FDG uptake on PET also be due to collateral blood flow, rather than a hypermetabolic mass?" A literature search identified one published report in the thoracic imaging literature of focal liver uptake in this same region on FDG-PET in two lung cancer patients with SVC obstruction (1). Given the previously reported PET finding and the CT features favoring benignity of the lesion, liver biopsy was deferred in favor of CT followup, which thereafter documented stability of the hepatic finding for 14 months (Fig. 7) and favored a nonmalignant etiology.
Discussion
In patients with SVC obstruction, areas of focal increased hepatic blood flow secondary to collateralization and systemic-portal venous shunting have been well documented. The result of this shunting has previously been demonstrated as abnormal enhancement on contrast-enhanced CT and as focal increased radiotracer uptake on nuclear medicine Tc-99m sulfur colloid scan, sometimes referred to as the "focal hepatic hot spot" sign (2, 3, (4) (5) (6) . This finding of focal hepatic enhancement or focal increased radiotracer activity is thought to be due to high concentrations of injected contrast or radiopharmaceuticals delivered to the left portal or subcapsular liver veins via collateral flow. There are several potential collateral pathways in SVC obstruction. These include the internal thoracic vein to the portal vein via the umbilical or paraumbilical veins, leading to focal flow to the liver in the region of the falciform ligament (7). There are also the lateral thoracic veins, superficial veins, azygoshemiazygos, and paravertebral collateral systems (6) (7) (8) .
In this patient with lymphoma, contrast-enhanced CT demonstrated obstruction of the SVC with internal thoracic collaterals to the anterior paraumbilical vessels as well as azygos/hemiazygos and paravertebral collateralization. On early pulmonary arterial-phase CT, a focal nonmasslike area of hypoattenuation was noted adjacent to the falciform ligament, which demonstrated avid enhancement during the portal venous phase. Subsequent PET then demonstrated focal increased FDG uptake in this same region. It is important to remember that the liver has been reported to be frequently involved in patients with nonHodgkin's lymphoma (9) . Indeed, in a patient being staged for known malignancy without SVC obstruction, focally increased FDG accumulation at a site of abnormal attenuation/ enhancement on CT would have high specificity for malignancy. FDG-PET has a reported specificity of between 90% and 96% for liver metastases from gastrointestinal primaries (10) (11) (12) . Hence, it is important for interpreters of PET to be aware of this phenomenon in patients with SVC obstruction as a potential false positive mimicking hepatic malignancy.
If further imaging evaluation to confirm false positive due to SVC obstruction is desired, the PET study could be repeated using an intravenous injection site on the lower extremity (for example, in a foot vein). The initial passage of concentrated radiotracer from the lower extremity via the nonobstructed inferior vena cava (rather than from upper extremity via collaterals bypassing the obstructed superior vena cava) would not be expected to reproduce a false positive hepatic finding due to SVC obstruction. This result has been confirmed using Tc-99m sulfur colloid in a patient with mediastinal mass due to metastatic breast cancer. Injection via the right antecubital fossa revealed a warm spot within the anterior liver, but no focal hepatic uptake with injection of the dorsum of the right foot (5) .
In the case of our patient, IR did not feel that a repeated PET/CT was needed for patient management and therefore opted to spare him the additional cost and radiation. After documented continued stability of the hepatic finding on CT for a total of 14 months, the patient was lost to followup. Considering the stability and the other features in this patient, it is thought very likely that the hepatic PET finding was also benign, related to the collateral blood flow of SVC obstruction. In a patient with SVC obstruction and isolated focal hepatic activity on FDG-PET along the falciform, interpreters of PET should consider this artifact in the differential. . Additional followup, contrast-enhanced CT was performed 14 months after the initial CT. These axial images were obtained in early arterial contrast phase following the administration of 80mL of Omnipaque-350 intravenous contrast via the right upper extremity. During this time, there was interval decrease in the size of the mediastinal mass (white arrow, A). A persistent region of parenchymal hypoattenuation was again seen involving segment IV of the left lobe of the liver (B-D). Stability of this hepatic finding over time lends support to the hypothesis that the increased PET activity associated with this lesion was nonmalignant in etiology.
